Keyword: PET/CT

Photo

Kickstarted imaging

First total body PET/CT scanner cleared for clinical use

The first total-body positron emission tomography/computed tomography (PET/CT) that can acquire a 3D image of the human body in a single position received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in January 2019. Its forthcoming commercial availability for clinical use in the United States later this year is the milestone achievement of a multi-institutional consortium…

Photo

Imaging agent

PET/CT tracer offers better diagnosis of acute venous thromboembolism

A first-in-human study reports that the novel positron emission tomography/computed tomography (PET/CT) tracer 18F-GP1 showed excellent image quality and a high detection rate for the diagnosis of acute venous thromboembolism (VTE). Well-tolerated in patients, 18F-GP1 PET/CT also identified blood clots in distal veins of the leg below the knee, where conventional imaging has limitations.

Photo

Promising diagnostic tool

Tracing tau tangles against Alzheimer’s

Researchers at Johns Hopkins Medicine have identified in live human brains new radioactive “tracer” molecules that bind to and “light up” tau tangles, a protein associated with a number of neurodegenerative diseases including Alzheimer’s disease and other related dementias. Two studies will be published back-to-back in the December issue of Journal of Nuclear Medicine—one as featured…

Photo

Digital PET imaging

Digital Photon Counting improves diagnostic accuracy

Built as the first commercially available scanner to deliver truly digital PET, the Vereos PET/CT, from Philips, offers revolutionary Digital Photon Counting technology. The science behind this scanner evolution is ‘quite complicated’, agrees Piotr Maniawski, Director of Clinical Science Nuclear Medicine at Philips Healthcare, yet the improved performance is significant, particularly when…

Photo

PET-scan

Imaging agent helps predicting lung cancer therapy success

With the help of a new radioactive tracer, doctors can predict with more than 80 percent accuracy how well a widely-used lung cancer drug will combat tumors, according to researchers at Stanford. The researchers developed a PET scan-compatible imaging agent engineered to seek out a specific mutation found in nonsmall cell lung cancer (which accounts for about 80 percent of lung cancers), bind to…

Photo

Celesteion PET-CT

Making a difference with Dual Modality Imaging

The Clinica Creu Blanca Diagnostic Group in Barcelona, Spain, is the first clinic in Europe to use Canon Medical System’s new Celesteion PET-CT Scanner. Dr. Xavier Alomar, Head of the Diagnostic Imaging Department at the Clinic, explains how the new system has opened up a large field of diagnostic possibilities for the Group in Metabolic Medicine in Oncology, Neurology, Cardio­logy and…

Photo

Combined techniques

Raising the bar higher in CRC imaging

Combining molecular information and high contrast resolution may well improve current performance in colorectal cancer (CRC) cases, according to Vicky Goh, who presented the latest results on PET/MRI during the last European Society of Medical Oncology (ESMO) meeting in Madrid PET/MRI brings the best of both modalities together: high contrast to noise and high spatial resolution combined with…

Photo

Hybrid

The whole is greater than the sum of its parts

‘The combination of nuclear medicine and modern imaging procedures such as CT and MRI is becoming increasingly important in the diagnosis, treatment planning and aftercare of cancerous diseases,’ explains Professor Katrine Åhlström Riklund, who presides over the newly established European Society for Hybrid Medical Imaging, ESHI.

Photo

Head and neck

Imaging scans track down persistent cancer cells

Head and neck cancer patients may no longer have to undergo invasive post-treatment surgery to remove remaining cancer cells, as research shows that innovative scanning-led surveillance can help identify the need for, and guidance of, neck dissection. The study from the Universities of Birmingham and Warwick and University Hospitals Coventry and Warwickshire used advanced imaging to identify…

Photo

Nuclear medicine

Eckert & Ziegler expands cooperation program with drug developers

Eckert & Ziegler AG, a specialist for isotope-based applications in medicine, science and industry, is expanding its cooperation program with promising drug developers in the field of nuclear medicine and will support Curasight, a spin-off based on research by the group of Professor Andreas Kjaer at the National University Hospital (Rigshospitalet) and University of Copenhagen, in obtaining…

Photo

Tissue definition

PET/MR is promising

PET/MR has long been studied for oncology but the technique also holds promise in cardiovascular applications, according to a panel of experts at the recent International Conference on Nuclear Cardiology and Cardiac CT (ICNCT).

Photo

Drawing radiology and nuclear medicine together

‘Let’s work as a team!’

Dr Gerald Antoch, professor of radiology and chairman of the department of diagnostic and interventional radiology at Düsseldorf University Hospital and active member of several scientific societies, delivered the prestigious Wilhelm Conrad Röntgen Honorary Lecture at ECR 2015 on ‘Hybrid imaging: Let the two worlds of radiology and nuclear medicine come together’. Report: Marcel Rasch

Photo

Nuclear Medicine in Practice

Defining a role and routine differences

Before 2013, when Professor Dietmar Dinter became partner of Radiologie Schwetzingen, a multi-discipline group practice specialised in radiology and nuclear medicine, he was senior resident at the Institute of Clinical Radiology and Nuclear Medicine at University Hospital Mannheim (2003-2012) and head of its Nuclear Medicine Department (2009-2012). Was his work in nuclear medicine altered by the…

Photo

Vulnerable plaque imaging

Looking for the perfect modality

What's the ideal solution for vulnerable plaque imaging? 'A non-invasive imaging procedure with high spatial and temporal resolution, and without radiation exposure, and which provides information on coronary plaque composition precisely and in series.' Report: Axel Viola

111 show more articles